The has released a podcast promoting this month’s Biotech 2009 conference in Raleigh. Joan Siefert Rose, president of the CED, announced the release on Wednesday.
CED’s Biotech 2009 conference is scheduled for Monday, Feb. 16 and Tuesday, Feb. 17 at the Raleigh Convention Center, 500 S. Salisbury St. This is the 18th year for the event.
In the , Dr. Richard Kent discusses the relevance of the conference and the state of biotech in North Carolina. Kent is a venture partner with Intersouth Partners in Durham and previously served as CEO of Serenex.
“This will be the first major biotech conference post-President Barack Obama’s inauguration,” said Kent. “Given the economy and the state of funding of biotech conferences, there is a need for CEOs especially to be intensively networking to try to build and finance their companies. Biotech 2009 is a fantastic venue, and I encourage anyone in the biotech industry to attend this conference.”
Kent will serve as a moderator for the “Leadership Issues in Changing Times” panel at the conference.
Panelists include John J. Campbell, founder, chairman and CEO of Campbell Alliance; Colin Goddard, Ph.D., CEO of OSI Pharmaceuticals, Inc.; and H. Stewart Parker, former president and CEO of Targeted Genetics Corp.
CED’s Biotech 2009 will feature opening remarks from Gov. Bev Perdue and Sen. Richard Burr, R-N.C.. Keynote speakers include James C. Mullen, president and CEO of Biogen Idec; Holden Thorp, chancellor of the University of North Carolina at Chapel Hill; Victor J. Dzau, M.D., chancellor of Health Affairs at Duke University, president and CEO of Duke University Health System and James B. Duke Professor of Medicine; and Oliver Smithies, D. Phil., Nobel laureate and excellence professor in the Department of Pathology at the University of North Carolina at Chapel Hill.
CED is headquartered in the Research Triangle Park and is the oldest and largest entrepreneurial support organization in the nation. It has more than 5,500 active members.